Musely
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 1.2m | 2.2m | 2.9m | 3.2m | 3.2m |
% growth | - | 77 % | 32 % | 10 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | N/A | Seed | |
$6.2m | Series A | ||
$16.0m | Series B | ||
N/A | $4.0m | Series B | |
N/A | N/A | Convertible | |
N/A | N/A | - | |
Total Funding | AUD40.5m |
Recent News about Musely
EditMusely operates in the online skincare market, providing prescription skincare treatments directly to consumers. The company primarily serves individuals seeking effective solutions for anti-aging and various skin conditions such as melasma and dark spots. Musely's business model revolves around telemedicine consultations with dermatologists, who prescribe personalized skincare treatments. These treatments are then delivered directly to the customer's home. The company generates revenue through the sale of these prescription products and telemedicine services. Musely leverages the expertise of dermatologists like Dr. Marie Jhin to offer scientifically-backed skincare solutions. The company also engages customers through educational content and testimonials, enhancing trust and credibility.
Keywords: prescription skincare, telemedicine, anti-aging, melasma treatment, dark spots, dermatology, personalized treatments, online consultations, home delivery, skincare solutions.